• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Kop et al. (2005) "Ambulatory monitoring of physical activity and symptoms..."

WillowJ

คภภเє ɠรค๓թєl
Messages
4,940
Location
WA, USA
Kop WJ, Lyden A, Berlin AA, Ambrose K, Olsen C, Gracely RH, Williams DA,
Clauw DJ. "Ambulatory monitoring of physical activity and symptoms in
fibromyalgia and chronic fatigue syndrome." Arthritis Rheum. 2005
Jan;52(1):296-303. PMID: 15641057

Department of Medical and Clinical Psychology, Uniformed Services University
of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA.
wjkop@usuhs.mil

Abstract

OBJECTIVE: Fibromyalgia (FM) and chronic fatigue syndrome (CFS) are
associated with substantial physical disability. Determinants of
self-reported physical disability are poorly understood. This investigation
uses objective ambulatory activity monitoring to compare patients with FM
and/or CFS with controls, and examines associations of ambulatory activity
levels with both physical function and symptoms during activities of daily
life.

METHODS: Patients with FM and/or CFS (n = 38, mean +/- SD age 41.5 +/- 8.2
years, 74% women) completed a 5-day program of ambulatory monitoring of
physical activity and symptoms (pain, fatigue, and distress) and results
were compared with those in age-matched controls (n = 27, mean +/- SD age
38.0 +/- 8.6 years, 44% women). Activity levels were assessed continuously,
ambulatory symptoms were determined using electronically time-stamped
recordings at 5 time points during each day, and physical function was
measured with the 36-item Short Form health survey at the end of the 5-day
monitoring period.

RESULTS: Patients had significantly lower peak activity levels than controls
(mean +/- SEM 8,654 +/- 527 versus 12,913 +/- 1,462 units; P = 0.003) and
spent less time in high-level activities when compared with controls (P =
0.001). In contrast, patients had similar average activity levels as those
of controls (mean +/- SEM 1,525 +/- 63 versus 1,602 +/- 89; P = 0.47). Among
patients, low activity levels were associated with worse self-reported
physical function over the preceding month. Activity levels were inversely
related to concurrent ambulatory pain (P = 0.031) and fatigue (P < 0.001).
Pain and fatigue were associated with reduced subsequent ambulatory activity
levels, whereas activity levels were not predictive of subsequent symptoms.

CONCLUSION: Patients with FM and/or CFS engaged in less high-intensity
physical activities than that recorded for sedentary control subjects. This
reduced peak activity was correlated with measures of poor physical
function. The observed associations may be relevant to the design of
behavioral activation programs, because activity levels appear to be
contingent on, rather than predictive of, symptoms.

Another one to add to your collection of articles showing that deconditioning is not causative nor a perpetuating factor but rather, low activity levels are actually a result of disease.